776
Views
40
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for the treatment of mucopolysaccharidoses

, , , , , , , , , & show all
Pages 9-26 | Received 03 Apr 2015, Accepted 19 Nov 2015, Published online: 09 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Alberto B. Burlina & Vincenza Gragnaniello. (2022) Newborn screening of mucopolysaccharidosis type I. Critical Reviews in Clinical Laboratory Sciences 59:4, pages 257-277.
Read now
Roberto Giugliani, Amauri Dalla Corte, Fabiano Poswar, Cláudia Vanzella, Dafne Horovitz, Mariluce Riegel, Guilherme Baldo & Filippo Vairo. (2018) Intrathecal/Intracerebroventricular enzyme replacement therapy for the mucopolysaccharidoses: efficacy, safety, and prospects. Expert Opinion on Orphan Drugs 6:7, pages 403-411.
Read now
Edward H. Schuchman, John Mitchell & Alex Solyom. (2017) Morbidity and mortality associated with Farber disease and prospects for therapy. Expert Opinion on Orphan Drugs 5:9, pages 717-726.
Read now
Roselena S. Schuh, Guilherme Baldo & Helder F. Teixeira. (2016) Nanotechnology applied to treatment of mucopolysaccharidoses. Expert Opinion on Drug Delivery 13:12, pages 1709-1718.
Read now

Articles from other publishers (36)

Camilla Matassini, Francesca Clemente & Francesca Cardona. 2023. Carbohydrate‐Based Therapeutics. Carbohydrate‐Based Therapeutics 245 292 .
Pascale Tuyaa-Boustugue, Ingrid Jantzen, Haoyue Zhang, Sarah P. Young, Pierre Broqua, Mireille Tallandier & Eugeni Entchev. (2023) Reduction of lysosome abundance and GAG accumulation after odiparcil treatment in MPS I and MPS VI models. Molecular Genetics and Metabolism Reports 37, pages 101011.
Crossref
Natalia Vallejo Alzate & Paula M. Hurtado. (2022) El Síndrome de Morquio en Colombia desde la molécula a la clínica. Pediatría 54:4, pages 146-154.
Crossref
Marialaura Marchetti, Serena Faggiano & Andrea Mozzarelli. (2022) Enzyme Replacement Therapy for Genetic Disorders Associated with Enzyme Deficiency. Current Medicinal Chemistry 29:3, pages 489-525.
Crossref
N. Vishal Gupta, K. Trideva Sastri, M. Sharadha, Souvik Chakraborty, V. Balamuralidhara & Amit Alexander. 2022. Drug Delivery Systems for Metabolic Disorders. Drug Delivery Systems for Metabolic Disorders 281 299 .
Kylie Tingley, Doug Coyle, Ian D. Graham, Pranesh Chakraborty, Kumanan Wilson & Beth K. Potter. (2021) Stakeholder perspectives on clinical research related to therapies for rare diseases: therapeutic misconception and the value of research. Orphanet Journal of Rare Diseases 16:1.
Crossref
Katherine Ackerman Porter, Cara O’Neill, Elise Drake, Samantha Parker, Maria L. Escolar, Stacey Montgomery, William Moon, Carolyn Worrall & Holly L. Peay. (2020) Parent Experiences of Sanfilippo Syndrome Impact and Unmet Treatment Needs: A Qualitative Assessment. Neurology and Therapy 10:1, pages 197-212.
Crossref
Yannick N. T. van den Eeden, Niklas Unter Ecker, Holger Kleinertz, Thorsten Gehrke & Tobias M. Ballhause. (2021) Total Hip Arthroplasty in a Patient with Mucopolysaccharidosis Type IVB. Case Reports in Orthopedics 2021, pages 1-8.
Crossref
Roberto Giugliani. 2021. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 501 562 .
Berna Seker Yilmaz, James Davison, Simon A. Jones & Julien Baruteau. (2020) Novel therapies for mucopolysaccharidosis type III . Journal of Inherited Metabolic Disease 44:1, pages 129-147.
Crossref
Christine í Dali, Samuel Groeschel, Mihai Moldovan, Mohamed H. Farah, Ingeborg Krägeloh‐Mann, Margaret Wasilewski, Jing Li, Norman Barton & Christian Krarup. (2020) Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study. Annals of Clinical and Translational Neurology 8:1, pages 66-80.
Crossref
Pâmella Borges, Gabriela Pasqualim, Roberto Giugliani, Filippo Vairo & Ursula Matte. (2020) Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes. Orphanet Journal of Rare Diseases 15:1.
Crossref
Giulia Polo, Daniela Gueraldi, Antonella Giuliani, Laura Rubert, Chiara Cazzorla, Leonardo Salviati, Antonio Marzollo, Alessandra Biffi, Alessandro P. Burlina & Alberto B. Burlina. (2020) The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I. Clinical Chemistry and Laboratory Medicine (CCLM) 58:12, pages 2063-2072.
Crossref
Vincenza Gragnaniello, Daniela Gueraldi, Laura Rubert, Francesca Manzoni, Chiara Cazzorla, Antonella Giuliani, Giulia Polo, Leonardo Salviati & Alberto Burlina. (2020) Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature. International Journal of Neonatal Screening 6:4, pages 85.
Crossref
Gustavo Egea, Francesc Jiménez-Altayó & Victoria Campuzano. (2020) Reactive Oxygen Species and Oxidative Stress in the Pathogenesis and Progression of Genetic Diseases of the Connective Tissue. Antioxidants 9:10, pages 1013.
Crossref
Christine í Dali, Caroline Sevin, Ingeborg Krägeloh-Mann, Roberto Giugliani, Norio Sakai, James Wu & Margaret Wasilewski. (2020) Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial. Molecular Genetics and Metabolism 131:1-2, pages 235-244.
Crossref
Eugeni Entchev, Ingrid Jantzen, Philippe Masson, Stephanie Bocart, Bruno Bournique, Jean-Michel Luccarini, Andre Bouchot, Olivier Lacombe, Jean-Louis Junien, Pierre Broqua & Mireille Tallandier. (2020) Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI—Evidence from in vitro and in vivo models. PLOS ONE 15:5, pages e0233032.
Crossref
Tran Kiem Hao, Nguyen Thi Diem Chi, Nguyen Thi Hong Duc & Nguyen Thi Kim Hoa. (2020) A case study of three patients with mucopolysaccharidoses in Hue Central Hospital. SAGE Open Medical Case Reports 8, pages 2050313X2093824.
Crossref
Steven Marionneaux. 2020. Rodak's Hematology. Rodak's Hematology 445 465 .
Lin, Lee, Lo, Tu, Chang, Chang, Chiu, Chang, Tsai, Niu, Chuang & Lin. (2019) An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan. Diagnostics 9:4, pages 140.
Crossref
Diana Rojas Málaga, Ana Carolina Brusius-Facchin, Marina Siebert, Gabriela Pasqualim, Maria Luiza Saraiva-Pereira, Carolina F.M de Souza, Ida V.D. Schwartz, Ursula Matte & Roberto Giugliani. (2019) Sensitivity, advantages, limitations, and clinical utility of targeted next-generation sequencing panels for the diagnosis of selected lysosomal storage disorders. Genetics and Molecular Biology 42:1 suppl 1, pages 197-206.
Crossref
Paul J. Orchard. (2018) Cellular Therapy in Rare Childhood Neurologic Disease: Lessons, Outcomes, and Access. Journal of Child Neurology 33:14, pages 877-881.
Crossref
Sandra Pohl, Alexandra Angermann, Anke Jeschke, Gretl Hendrickx, Timur A Yorgan, Georgia Makrypidi‐Fraune, Anita Steigert, Sonja C Kuehn, Tim Rolvien, Michaela Schweizer, Till Koehne, Mona Neven, Olga Winter, Renata Voltolini Velho, Joachim Albers, Thomas Streichert, Jan M Pestka, Christina Baldauf, Sandra Breyer, Ralf Stuecker, Nicole Muschol, Timothy M Cox, Paul Saftig, Chiara Paganini, Antonio Rossi, Michael Amling, Thomas Braulke & Thorsten Schinke. (2018) The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover. Journal of Bone and Mineral Research 33:12, pages 2186-2201.
Crossref
Daniela Concolino, Federica Deodato & Rossella Parini. (2018) Enzyme replacement therapy: efficacy and limitations. Italian Journal of Pediatrics 44:S2.
Crossref
Rita Barone, Alessandra Pellico, Annarita Pittalà & Serena Gasperini. (2018) Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses. Italian Journal of Pediatrics 44:S2.
Crossref
Hsiang‐Yu Lin, Chung‐Lin Lee, Yun‐Ting Lo, Tuan‐Jen Wang, Sung‐Fa Huang, Tzu‐Lin Chen, Yu‐Shan Wang, Dau‐Ming Niu, Chih‐Kuang Chuang & Shuan‐Pei Lin. (2018) The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses. Molecular Genetics & Genomic Medicine 6:6, pages 982-992.
Crossref
Francesca Maccari, Fabio Galeotti, Veronica Mantovani, Lucia Zampini, Lucia Padella, Laura Rigon, Daniela Concolino, Agata Fiumara, Elisa Pascale, Annarita Pittalà, Tiziana Galeazzi, Chiara Monachesi, Rita Lucia Marchesiello, Giovanni Coppa, Orazio Gabrielli & Nicola Volpi. (2018) Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis. Analytical Biochemistry 557, pages 34-41.
Crossref
Eurico Camargo Neto, Jaqueline Schulte, Jamile Pereira, Heydy Bravo, Claudio Sampaio-Filho & Roberto Giugliani. (2018) Neonatal screening for four lysosomal storage diseases with a digital microfluidics platform: Initial results in Brazil. Genetics and Molecular Biology 41:2, pages 414-416.
Crossref
Lidia Gaffke, Karolina Pierzynowska, Ewa Piotrowska & Grzegorz Węgrzyn. (2017) How close are we to therapies for Sanfilippo disease?. Metabolic Brain Disease 33:1, pages 1-10.
Crossref
Maurizio Scarpa, Paul J. Orchard, Angela Schulz, Patricia I. Dickson, Mark E. Haskins, Maria L. Escolar & Roberto Giugliani. (2017) Treatment of brain disease in the mucopolysaccharidoses. Molecular Genetics and Metabolism 122, pages 25-34.
Crossref
N. WilliamsD. ChalloumasD. KetteridgeP. J. CundyD. M. Eastwood. (2017) The mucopolysaccharidoses. The Bone & Joint Journal 99-B:9, pages 1132-1139.
Crossref
Valeska Lizzi Lagranha, Barbara Zambiasi Martinelli, Guilherme Baldo, Giuseppe Ávila Testa, Talita Giacomet de Carvalho, Roberto Giugliani & Ursula Matte. (2017) Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatment. Journal of Materials Science: Materials in Medicine 28:3.
Crossref
C. Yu. 2017. Biomarkers in Inborn Errors of Metabolism. Biomarkers in Inborn Errors of Metabolism 191 209 .
Edward H. Schuchman. (2016) Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:9, pages 1459-1471.
Crossref
Christiane Auray-Blais, Pamela Lavoie, Shunji Tomatsu, Vassili Valayannopoulos, John J. Mitchell, Julian Raiman, Maxime Beaudoin, Bruno Maranda & Joe T.R. Clarke. (2016) UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses. Analytica Chimica Acta 936, pages 139-148.
Crossref
Sun H. Peck, Margret L. Casal, Neil R. Malhotra, Can Ficicioglu & Lachlan J. Smith. (2016) Pathogenesis and treatment of spine disease in the mucopolysaccharidoses. Molecular Genetics and Metabolism 118:4, pages 232-243.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.